Treatment Side Effects Clinical Trials

12 recruiting

Treatment Side Effects Trials at a Glance

13 actively recruiting trials for treatment side effects are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Early Phase 1 with 7 trials, with the heaviest enrollment activity in Shanghai, Shanghai, and Gothenburg. Lead sponsors running treatment side effects studies include Shanghai Juncell Therapeutics, Northwestern University, and Hacettepe University.

Browse treatment side effects trials by phase

Treatments under study

About Treatment Side Effects Clinical Trials

Looking for clinical trials for Treatment Side Effects? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Treatment Side Effects trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Treatment Side Effects clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Not Applicable

Surgical Approach to Uterine Septum

TreatmentSurgical ComplicationTreatment Side Effects+2 more
Northwestern University40 enrolled1 locationNCT06315582
Recruiting
Early Phase 1

A Study of GC203 TIL in PDCA (RJ)

Pancreatic CancerTreatment Side EffectsTumor Infiltrating Lymphocytes+1 more
Shanghai Juncell Therapeutics10 enrolled1 locationNCT06828328
Recruiting
Early Phase 1

A Study of TIL in Advanced Solid Tumors (DFGD)

Advanced Solid TumorTreatment Side EffectsEffects of Immunotherapy+1 more
Shanghai Juncell Therapeutics30 enrolled1 locationNCT06488950
Recruiting
Early Phase 1

A Study of GC101 TIL in Advanced Melanoma (10hospital)

Advanced MelanomaTreatment Side EffectsEffects of Immunotherapy+1 more
Shanghai Juncell Therapeutics50 enrolled1 locationNCT05098184
Recruiting
Early Phase 1

A Study of GC201 TIL in Advanced Gynecologic Tumors (10hospital)

Treatment Side EffectsEffects of ImmunotherapyAdvanced Gynecologic Tumors+1 more
Shanghai Juncell Therapeutics50 enrolled1 locationNCT05098171
Recruiting
Early Phase 1

A Study of GC101 TIL in Advanced Breast Cancer (10hospital)

Breast CancerAdvanced Breast CancerTreatment Side Effects+1 more
Shanghai Juncell Therapeutics50 enrolled1 locationNCT05142475
Recruiting
Early Phase 1

A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)

Treatment Side EffectsEffects of ImmunotherapyTumor Infiltrating Lymphocyte+2 more
Shanghai Juncell Therapeutics50 enrolled1 locationNCT05098197
Recruiting

Body Composition and Psychosocial Factors in ICI-Treated Cancer Patients

CancerTreatment Side EffectsCachexia+1 more
Hacettepe University200 enrolled1 locationNCT07130981
Recruiting

Trazodone vs. Quetiapine for the Treatment of ICU Delirium

Treatment Side EffectsDeliriumMorality+5 more
University of Southern California60 enrolled1 locationNCT05307003
Recruiting
Early Phase 1

A Clinical Study on TIL for the Treatment of Advanced Solid Tumors

Advanced Solid TumorTreatment Side EffectsEffects of Immunotherapy+1 more
Shanghai Juncell Therapeutics50 enrolled1 locationNCT05087745
Recruiting
Not Applicable

NT-proBNP to Assess Trastuzumab-induced Cardiotoxicity

Breast CancerCardiotoxicityTreatment Side Effects
Vastra Gotaland Region700 enrolled1 locationNCT06340516
Recruiting
Not Applicable

Surgery Versus Endoscopic Resection for Incompletely Removed Early Colon CAnceR

Treatment Side Effects
Norwegian Department of Health and Social Affairs304 enrolled3 locationsNCT06057350
Recruiting
Phase 2

Investigating the effect of medicinal cannabis on the symptoms and side effects of chemotherapy in people with cancer.

chemotherapy treatment side effects
Central Adelaide Local Health Network (CALHN)176 enrolled3 locationsACTRN12622000419763